These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

61 related items for PubMed ID: 14624206

  • 1. Abnormal prolactin elevation in a schizophrenic patient in treatment with quetiapine and mirtazapine. The role of opioid system.
    Orlandi V, Speca A, Salviati M, Biondi M.
    J Clin Psychopharmacol; 2003 Dec; 23(6):677-9. PubMed ID: 14624206
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. High plasma prolactin levels after long-term neuroleptic treatment.
    Zelaschi NM, Delucchi GA, Rodriguez JL.
    Biol Psychiatry; 1996 May 15; 39(10):900-1. PubMed ID: 8860193
    [No Abstract] [Full Text] [Related]

  • 5. Dose-dependent constipation with higher doses of quetiapine: a case series.
    Raedler TJ, Reimer J, Wiedemann K.
    Int Clin Psychopharmacol; 2007 Jul 15; 22(4):244-6. PubMed ID: 17519649
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mirtazapine add-on improves olanzapine effect on negative symptoms of schizophrenia.
    Caforio G, Di Giorgio A, Rampino A, Rizzo M, Romano R, Taurisano P, Fazio L, De Simeis G, Ursini G, Blasi G, Nardini M, Mancini M, Bertolino A.
    J Clin Psychopharmacol; 2013 Dec 15; 33(6):810-2. PubMed ID: 24113675
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Quetiapine indication shift in the elderly: diagnosis and dosage in 208 psychogeriatric patients from 2000 to 2006.
    Hilwerling L, Juckel G, Schröder SG.
    Int J Geriatr Psychiatry; 2007 May 15; 22(5):401-4. PubMed ID: 17096460
    [Abstract] [Full Text] [Related]

  • 18. Urinary retention following repeated high-dose quetiapine.
    Sokolski KN, Brown BJ, Melden M.
    Ann Pharmacother; 2004 May 15; 38(5):899-900. PubMed ID: 15039480
    [No Abstract] [Full Text] [Related]

  • 19. [An open study on the efficacy and tolerability of quetiapine treatment of patients with schizophrenia].
    Beszłej JA, Grzesiak M.
    Psychiatr Pol; 2005 May 15; 39(2):293-307. PubMed ID: 15881624
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia.
    Lee KU, Jeon YW, Lee HK, Jun TY.
    Hum Psychopharmacol; 2009 Aug 15; 24(6):447-52. PubMed ID: 19606454
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.